BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16919723)

  • 1. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
    Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F; Schmitz T; Bernkop-Schnürch A
    Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF; Hombach J; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
    J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J; Hoyer H; Bernkop-Schnürch A
    Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M; Hoffer M
    J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
    J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
    Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
    Föger F; Kafedjiiski K; Hoyer H; Loretz B; Bernkop-Schnürch A
    J Drug Target; 2007 Feb; 15(2):132-9. PubMed ID: 17365284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
    Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N
    Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
    Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
    Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.
    Hirunpanich V; Murakoso K; Sato H
    Int J Pharm; 2008 Mar; 351(1-2):133-43. PubMed ID: 18082981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved paracellular uptake by the combination of different types of permeation enhancers.
    Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
    Johnson BM; Charman WN; Porter CJ
    AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
    Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
    Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.